BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9829743)

  • 1. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.
    Lazar AD; Winter MR; Nogueira CP; Larson PS; Finnemore EM; Dolan RW; Fuleihan N; Chakravarti A; Zietman A; Rosenberg CL
    Clin Cancer Res; 1998 Nov; 4(11):2787-93. PubMed ID: 9829743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma.
    Matsuura K; Shiga K; Yokoyama J; Saijo S; Miyagi T; Takasaka T
    Anticancer Res; 1998; 18(1A):453-8. PubMed ID: 9568119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix.
    O'sullivan MJ; Rader JS; Gerhard DS; Li Y; Trinkaus KM; Gersell DJ; Huettner PC
    Hum Pathol; 2001 May; 32(5):475-8. PubMed ID: 11381364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features.
    El-Naggar AK; Hurr K; Huff V; Luna MA; Goepfert H; Batsakis JG
    Clin Cancer Res; 1996 May; 2(5):903-7. PubMed ID: 9816248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
    Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
    Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
    Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D
    Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
    Adamson R; Jones AS; Field JK
    Oncogene; 1994 Jul; 9(7):2077-82. PubMed ID: 8208554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
    Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
    Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
    dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
    Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
    Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
    Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.
    Tan D; Wiseman S; Zhou Y; Li Q; Ward P; Slocum HK; Alrawi S; Loree T; Hicks W; Rigual N; Anderson G; Stoler D
    Diagn Mol Pathol; 2004 Mar; 13(1):33-40. PubMed ID: 15163007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
    Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.